Search

Your search keyword '"C. Le Pechoux"' showing total 28 results
Start Over Author "C. Le Pechoux" Journal radiotherapy and oncology
28 results on '"C. Le Pechoux"'

2. PO-1246 Lung SBRT after pneumonectomy

Author

A. Botticella, A. Levy, O. Mercier, G. Auzac, A. Traore-Diallo, M. Frelaut, P. Pradere, C. Caramella, I. Kasraoui, B. Besse, D. Planchard, and C. Le Pechoux

Subjects
Oncology, Radiology, Nuclear Medicine and imaging, Hematology
Published
2022
Full Text
View/download PDF

4. PH-0280: Quality of surgery and RT in stage IIIN2 NSCLC: Insights from the Lung Adjuvant Radiotherapy trial

Author

Sara Ramella, Corinne Faivre-Finn, Y. Moukasse, C. Le Pechoux, P. Van Schil, Ramón Rami-Porta, Delphine Lerouge, P.A. Thomas, John G. Edwards, N. Pourel, and A. Bardet

Subjects
Oncology, Adjuvant radiotherapy, medicine.medical_specialty, Lung, medicine.anatomical_structure, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Stage (cooking), business
Published
2020
Full Text
View/download PDF

5. SP-0146: Against the motion: This house believes that hippocampus avoiding WBI is the current standard of care

Author

O. Henry, A. Levy, G. Auzac, Stéphanie Bolle, F. Dhermain, Angela Botticella, and C. Le Pechoux

Subjects
medicine.medical_specialty, Physical medicine and rehabilitation, Standard of care, Oncology, business.industry, Medicine, Hippocampus, Radiology, Nuclear Medicine and imaging, Hematology, Current (fluid), business, Motion (physics)
Published
2020
Full Text
View/download PDF

6. OC-0457: Stereotactic body radiation therapy (SBRT) for oligometastatic soft tissue sarcoma (STS)

Author

A. Levy, G. Auzac, S. Dumond, E. Tang, I. Chabert, Leila Haddag-Miliani, Olivier Mir, Charles Honoré, Matthieu Faron, O. Henry, Fadila Mihoubi, Andrea Cavalcanti, C. Le Pechoux, D. Jornet, P. Terrier, A. Le Cesne, Angela Botticella, and Julien Adam

Subjects
medicine.medical_specialty, Oncology, business.industry, Stereotactic body radiation therapy, Soft tissue sarcoma, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Radiology, medicine.disease, business
Published
2020
Full Text
View/download PDF

7. OC-0061 EORTC 22113-8113 Lungtech trial on SBRT of central lung tumors

Author

Dirk De Ruysscher, Kevin Franks, Corinne Faivre-Finn, Catherine Fortpied, M. Lambrecht, Yang Liu, S. Colette, Heike Peulen, V. Lewitzki, Rafal Dziadziuszko, José Belderbos, X. Geets, Fiona McDonald, Krzysztof Konopa, Syed A. Ahmad, C. Le Pechoux, N. Pourel, Ursula Nestle, N. Andratschke, M. Guckenberger, A.L. Grosu, C. Hurkmans, Yolande Lievens, Sonja Adebahr, and Munaza Ahmed

Subjects
Oncology, medicine.medical_specialty, Lung, medicine.anatomical_structure, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business
Published
2019
Full Text
View/download PDF

8. EP-1353 Lung cancer extrecerebral oligometastases/oligoprogression stereotactic irradiation

Author

Juliette Thariat, S. Danhier, Radj Gervais, J. Lequesne, Christos Chouaid, Isabelle Martel-Lafay, C. Loiseau, Dinu Stefan, C. Le Pechoux, Delphine Lerouge, V. Barraux, M. Kissel, Jean-Michel Grellard, and Jean-Christophe Faivre

Subjects
Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, Nuclear medicine, Lung cancer, medicine.disease, Stereotactic irradiation
Published
2019
Full Text
View/download PDF

9. PO-0779 Current management of limited-stage SCLC and CONVERT trial impact: an EORTC LCG survey

Author

Corinne Faivre-Finn, Lizza E.L. Hendriks, Baktiar Hasan, Thierry Berghmans, S. Falk, Martin Reck, A-M.C. Dingemans, Benjamin Besse, Silvia Novello, C. Le Pechoux, and A. Levy

Subjects
Oncology, Limited stage SCLC, medicine.medical_specialty, Current management, business.industry, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, business
Published
2019
Full Text
View/download PDF

10. EP-1686: Hafnium oxide nanoparticles and radiotherapy for solid tumors: a promising new treatment strategy

Author

F. Nguyen, K. Rubi Li, A. Mervoyer, Marco Rastrelli, S. Bonvalot, Guy Kantor, Zsuzsanna Papai, Jean-Pierre Bronowicki, C. Le Pechoux, Teresa T. Sy-Ortin, M. Delannes, Alessandro Gronchi, S. Carrere, P. Agoston, V. Moreno-Garcia, Juliette Thariat, Véronique Vendrely, P. Ruthowski, E. Le Prisé, B. Tiangco, R. Anghe, Marie-Pierre Sunyach, A.-S. Baumann, C. Le Tourneau, and Angela Hong

Subjects
Radiation therapy, Materials science, Oncology, medicine.medical_treatment, medicine, Nanoparticle, Treatment strategy, Radiology, Nuclear Medicine and imaging, Nanotechnology, Hematology, Hafnium oxide
Published
2018
Full Text
View/download PDF

12. PV-0208 Immune-related pneumonitis in NSCLC patients treated with ICI: impact of previous thoracic RT

Author

Aurélien Marabelle, David Planchard, Eric Deutsch, Roberto Ferrara, A. Gazzah, C. Le Pechoux, Lizza E.L. Hendriks, Tony Ibrahim, Benjamin Besse, Stéphane Champiat, J. Le Pavec, Pernelle Lavaud, P. Gustin, Angela Botticella, J-M. Michot, Laura Mezquita, and Caroline Caramella

Subjects
Oncology, medicine.medical_specialty, Immune system, business.industry, Internal medicine, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business, medicine.disease, Pneumonitis
Published
2019
Full Text
View/download PDF

13. EP-1250: Outcome after stereotactic radiotherapy for brain metastasis of lung cancer: a retrospective study

Author

F. Belkhir, Benjamin Besse, P. Xu, N. Grellier Adedjouma, C. Le Pechoux, A. Levy, F. Martinetti, A. Suissa, and David Planchard

Subjects
Oncology, medicine.medical_specialty, business.industry, Retrospective cohort study, Hematology, medicine.disease, Outcome (game theory), Stereotactic radiotherapy, Radiology Nuclear Medicine and imaging, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Lung cancer, business, Brain metastasis
Published
2016
Full Text
View/download PDF

15. PO-0805: Intensity Modulated Radiotherapy for the treatment of retroperitoneal sarcoma

Author

S.B. Silvie Bonvalot, D. Belemsagha, J. Brahim, Antonin Levy, Axel Le Cesne, C. Le Pechoux, F. Martinetti, and M.A.C.G. Maria Almudena Cascales

Subjects
medicine.medical_specialty, Oncology, business.industry, Radiology Nuclear Medicine and imaging, Medicine, Retroperitoneal sarcoma, Radiology, Nuclear Medicine and imaging, Radiology, Intensity modulated radiotherapy, Hematology, business
Published
2015
Full Text
View/download PDF

16. PO-0768: Evaluation of RT practice for limb soft tissue sarcomas and its impact on prognosis and toxicity

Author

Guy Kantor, Marie-Pierre Sunyach, Laurence Moureau-Zabotto, Florent Vilotte, Anne Ducassou, Georges Noël, Sophie Chapet, C. Llacer-Moscardo, M. Delannes, Juliette Thariat, S. Thezenas, Paul Sargos, C. Le Pechoux, Guillaume Vogin, and J. Fourquet

Subjects
Pathology, medicine.medical_specialty, Oncology, business.industry, Radiology Nuclear Medicine and imaging, Toxicity, Soft tissue, Medicine, Radiology, Nuclear Medicine and imaging, Hematology, business
Published
2016
Full Text
View/download PDF

17. OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice

Author

Corinne Faivre-Finn, Kate Haslett, C. Le Pechoux, Rafal Dziadziuszko, M. Guckenberger, Dirk De Ruysscher, and Ursula Nestle

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Radiology Nuclear Medicine and imaging, 030220 oncology & carcinogenesis, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business, Extensive-stage small cell lung cancer
Published
2016
Full Text
View/download PDF

18. PD-0045: Ph I/II study evaluating the impact of nanoparticules combined to pre-operative radiotherapy in soft tissue sarcoma

Author

Xavier Buy, Eric Deutsch, F. Martinetti, Antoine Italiano, E. Stoeckle, P. Terrier, T. de Baere, Paul Sargos, C. Le Pechoux, A. Le Cesne, Guy Kantor, S. Bonvalot, Jeannette Soria, and A. Levy

Subjects
medicine.medical_specialty, Oncology, business.industry, Radiology Nuclear Medicine and imaging, Pre operative radiotherapy, Soft tissue sarcoma, medicine, Radiology, Nuclear Medicine and imaging, Radiology, Hematology, medicine.disease, business, Surgery
Published
2015
Full Text
View/download PDF

19. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals

Author

E. Haddad, Pascal Piedbois, C. Le Pechoux, H Frikha, J.P. Le Bourgeois, and Lynn Martin

Subjects
Adult, Male, medicine.medical_specialty, Palliative care, medicine.medical_treatment, Eyelid Neoplasms, Radiation Tolerance, Radiotherapy, High-Energy, Scrotum, medicine, Humans, Radiology, Nuclear Medicine and imaging, Penile Neoplasms, Sarcoma, Kaposi, Kaposi's sarcoma, Acquired Immunodeficiency Syndrome, Chemotherapy, business.industry, Palliative Care, Remission Induction, Radiotherapy Dosage, Hematology, Middle Aged, medicine.disease, Combined Modality Therapy, Surgery, Radiation therapy, medicine.anatomical_structure, Oncology, Genital Neoplasms, Male, Genital neoplasm, Mouth Neoplasms, Sarcoma, Eyelid, business
Abstract

From January 1987 to December 1992, 420 patients with acquired immunodeficiency syndrome (AIDS)-related epidemic Kaposi's sarcoma (EKS) were treated with radiotherapy at the oncology department in the Henri Mondor Hospital. Of these, 146 (34.7%) exhibited tumours at 186 sites; 35 were oral, 102 eyelid or conjunctival (ophthalmic), and 49 penile or scrotal (genital) sites. Most patients had received prior chemotherapy. Radiation therapy consisted of 4 MV or 45 kV X-rays, depending on tumor size and location. Doses ranged from 10 to 30 Gy, according to tumor response and toxicity. In oral lesions mucosal reactions were often observed after relatively low doses of radiotherapy. In 27 patients receiving 15 Gy, severe reactions were observed in 6 (22%), moderate reactions in 4 (15%) and mild reactions in 17 (63%). By contrast, irradiation of eyelid or conjunctival lesions and genital lesions, was well-tolerated. Treatment was generally successful in achieving good symptom palliation. Eyelid and conjunctival Kaposi's sarcoma seemed to be more radiosensitive when compared with cutaneous sites: a high objective remission rate (96%, 98/102) was observed at doses ranging from 10 to 20 Gy. Penile and scrotal lesions showed a good response to low dose radiation (complete response was scored in 34/49 patients (69.4%)). A meticulous evaluation of tolerance was necessary. Toxicity of oropharyngeal irradiation at relatively low doses is an argument for a restrictive use of this procedure in oral lesions.

Published
1994
Full Text
View/download PDF

20. Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy

Author

Bernard Pierquin, Yves Otmezguine, Howard D. Thames, Jean-Jacques Mazeron, C. Le Pechoux, E. Calitchi, Jean-Marc Simon, Bernard Dubray, and J.P. Le Bourgeois

Subjects
Time Factors, medicine.medical_treatment, Brachytherapy, Breast Neoplasms, Adenocarcinoma, Lower risk, Breast cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, Treatment Failure, Cobalt Radioisotopes, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, business.industry, External irradiation, Radiotherapy Dosage, Hematology, Middle Aged, Iridium Radioisotopes, medicine.disease, Confidence interval, Oncology, Relative risk, Female, Implant, Neoplasm Recurrence, Local, Breast carcinoma, business, Nuclear medicine
Abstract

From 1971 to 1983, 398 (33 T 1 , 309 T 2 , 56 T 3 ) biopsy-proven breast adenocarcinomas were treated conservatively at Hopital Henri Mondor by an initial course of external irradiation (45 Gy, 25 fractions, 5 weeks) followed by interstitial iridium-192 implant for a further 37 Gy to the tumor. The mean interval between external irradiation and brachytherapy was 5.9 weeks (S.D. 1.7, range 1–18). Seventy-seven local failures were observed at 10–148 months (median 34.5). The actuarial probabilities (S.E.) of local control at 5 and 10 years were 0.86 (0.02) and 0.74 (0.03), respectively. The follow-up for patients free of local recurrence was 4–205 months (median 95). Multivariate analysis showed an increasing probability of local failure with longer interval between external irradiation and brachytherapy (Relative Risk [R.R.] 1.23 [95% confidence limits: 1.07, 1.41] per week, p = 0.005), and a lower risk of failure in case of complete tumor regression after external irradiation (R.R. 0.47 [0.25, 0.90], p = 0.022), and higher brachytherapy dose rate (R.R. 0.13 [0.02, 1.02] per Gy/h, p = 0.053). No influence of tumor size and total dose (possibly because only limited variations in total dose were observed), or histological grading (not performed in 140 [35%] patients) was found. Because of the lack of dose-control relationship, quantification of the effects of delay between external irradiation and brachytherapy (in terms of compensatory dose) and of dose rate (Incomplete Repair Model) was not possible. The present analysis suggests that the implant dose rate should be high (but no extrapolation can be made above 1 Gy/h) or that total dose should be increased to compensate lower dose rate. However, our data do not indicate how much extra dose is necessary, since no dose-control relationship was elicited. In addition, the treatment duration should remain as short as possible in order to maximize local control.

Published
1992
Full Text
View/download PDF

24. 95 Concomitant high dose rate endoluminal brachytherapy (HDR-BT) with external beam radiotherapy (EBRT) in non small cell lung cancer (NSCLC) a phase I HDD-BT dose scalation study

Author

M. Albano, Eric Lartigau, M. Delapierre, M. Perez-Payo, Pierre Ruffié, B. Roche, Alain Gerbaulet, C. Haie-Meder, C. Le Pechoux, Pierre Baldeyrou, Hugo Marsiglia, E. Briot, M. Bonomi, and T. Le Chevalier

Subjects
Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Brachytherapy, non-small cell lung cancer (NSCLC), Hematology, medicine.disease, Internal medicine, Concomitant, medicine, Radiology, Nuclear Medicine and imaging, External beam radiotherapy, Dose rate, business, Nuclear medicine
Published
1998
Full Text
View/download PDF

25. PO-0682: Prognostic factors and patterns of failure after post-op radiotherapy for epithelial thymic tumors

Author

A. Suissa, A. Levy, N. Grellier-Adedjouma, Elie Fadel, F. Belkhir, C. Le Pechoux, and P. Xu

Subjects
Oncology, Patterns of failure, medicine.medical_specialty, business.industry, medicine.medical_treatment, Thymic Tumors, Hematology, Radiation therapy, Radiology Nuclear Medicine and imaging, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business
Full Text
View/download PDF

27. EP-1245: BED <100Gy and ITV ≥20cc predict local relapse after stereotactic radiation therapy for lung cancer

Author

F. Belkhir, A. Suissa, C. Le Pechoux, F. Martinetti, A. Levy, N. Grellier-Adedjouma, and P. Xu

Subjects
Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Stereotactic radiation therapy, Hematology, medicine.disease, Radiology Nuclear Medicine and imaging, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Lung cancer, business
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results